Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Nov 17;89(10):1906-8.
doi: 10.1038/sj.bjc.6601400.

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer

Affiliations

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer

E J Bromwich et al. Br J Cancer. .

Abstract

The present study examined the relationship between tumour stage, grade, T-lymphocyte subset infiltration and survival in patients who had undergone potentially curative surgery for renal clear-cell cancer (n=73). Intratumoural CD4+ T-lymphocyte infiltrate was associated with poor cancer-specific survival, independent of grade, in this cohort.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Anderson JA, Dunnill MS (1965) Observations on the estimation of the quantity of emphysema in the lungs by the point-sampling method. Thorax 20: 462–466
    1. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 537: 539–545 - PubMed
    1. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, Novick A (1997) TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 992–993 - PubMed
    1. Kolbeck PC, Kaveggia FF, Johansson SL, Grune MT, Taylor RJ (1992) The relationships among tumor-infiltrating lymphocytes, histopathologic findings, and long-term clinical follow-up in renal cell carcinoma. Mod Pathol 5: 420–425 - PubMed
    1. Michael A, Pandha HS. (2003) Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies. Lancet Oncol 4: 215–223 - PubMed